An independent set of 10 pairs of bladder tumours and normal urothelium, similar to the set used for the discovery of explorative analyses, was utilised to validate the presence of cancer-specific methylation of SOX9 by an independent method, MS-PCR. The gene discussed is SOX9; the disease is cancer.